Toxic Adenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (15 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{ADG}} | {{CMG}} ; {{AE}} {{ADG}} | ||
==Overveiw== | ==Overveiw== | ||
The [[prevalence]] rates of toxic adenoma is 5-7% and 1-2% of all [[hyperthyroidism]] cases in women and men respectively. Toxic adenoma is more commonly seen in patients over 60 years. Similar to any [[thyroid]] disease females are more commonly affected by toxic adenoma than males. The female-to-male ratio is 5.9:1 for toxic adenoma. | |||
==Epidemiology== | ==Epidemiology== | ||
===Prevalance=== | |||
*Toxic adenoma [[prevalence]] is inversely related to a population’s dietary [[iodine]] sufficiency. | |||
*In women and men, the [[prevalence]] rate of toxic adenoma is 5-7% and 1-2%, respectively. | |||
==Demographics== | ==Demographics== | ||
===Age=== | ===Age=== | ||
The incidence of toxic adenoma increases with age; the median age at diagnosis is 50 years. | *The [[incidence]] of toxic adenoma increases with age; the median age at diagnosis is 50 years.<ref name="pmid7372787">{{cite journal |vauthors=Hamburger JI |title=Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules |journal=J. Clin. Endocrinol. Metab. |volume=50 |issue=6 |pages=1089–93 |year=1980 |pmid=7372787 |doi=10.1210/jcem-50-6-1089 |url=}}</ref> | ||
*Toxic adenoma is more commonly seen in patients over 60 years. | |||
===Race=== | ===Race=== | ||
There is no racial predilection to toxic adenoma. | There is no racial predilection to toxic adenoma. | ||
===Gender=== | ===Gender=== | ||
*Similar to any thyroid disease females are more commonly affected by toxic adenoma than males. | *Similar to any [[thyroid]] disease females are more commonly affected by toxic adenoma than males. | ||
*In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively. | *In women and men, the [[prevalence]] rate of palpable [[nodules]] is 5-7% and 1-2%, respectively. | ||
*The female-to-male ratio is 5.9:1 for toxic adenoma. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 00:26, 30 July 2020
|
Toxic Adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Template:T On the Web |
|
American Roentgen Ray Society Images of Toxic Adenoma epidemiology and demographics |
|
Risk calculators and risk factors for Toxic Adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overveiw
The prevalence rates of toxic adenoma is 5-7% and 1-2% of all hyperthyroidism cases in women and men respectively. Toxic adenoma is more commonly seen in patients over 60 years. Similar to any thyroid disease females are more commonly affected by toxic adenoma than males. The female-to-male ratio is 5.9:1 for toxic adenoma.
Epidemiology
Prevalance
- Toxic adenoma prevalence is inversely related to a population’s dietary iodine sufficiency.
- In women and men, the prevalence rate of toxic adenoma is 5-7% and 1-2%, respectively.
Demographics
Age
- The incidence of toxic adenoma increases with age; the median age at diagnosis is 50 years.[1]
- Toxic adenoma is more commonly seen in patients over 60 years.
Race
There is no racial predilection to toxic adenoma.
Gender
- Similar to any thyroid disease females are more commonly affected by toxic adenoma than males.
- In women and men, the prevalence rate of palpable nodules is 5-7% and 1-2%, respectively.
- The female-to-male ratio is 5.9:1 for toxic adenoma.
References
- ↑ Hamburger JI (1980). "Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules". J. Clin. Endocrinol. Metab. 50 (6): 1089–93. doi:10.1210/jcem-50-6-1089. PMID 7372787.